TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive DCE Board Approves Concepts for More Chemoprevention Projects, NEW RFAs for PV, Anti-Sense RNA Studies October 31, 1986
TCL Archive In Brief: Bogardus Heads ASTRO, Million President Elect; Woods Named Chief of NIC Contracts Review October 27, 1989
TCL Archive In Brief: OSHA May Take A Year To Read Comments On Proposed Workplace Smoking Ban February 23, 1996
